Print Issue: February 01, 2011

Robert G. Uzzo, MD, FACS

The Negative Prostate Biopsy Dilemma

The role of PSA as a cancer screening tool has recently been evaluated by several large high profile studies with varying interpretations of the data. Regardless of where one stands on the debate, among the clinical dilemmas of PSA-based screening is the negative biopsy conundrum where the reality remains that the best one can offer is, “Good news Mr. Smith, I don’t think you have prostate cancer.”

Active Surveillance Underused

SAN DIEGO—Almost half of all patients diagnosed with prostate cancer could be treated using active surveillance (AS) based on National Comprehensive Cancer Network (NCCN) guidelines, but fewer than 10% actually receive this treatment strategy, data from a recent study suggest.

Next post in CME Articles